Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic studyBen Van Calster, Kirsten Van Hoorde, L. Valentin et al.|BMJ|2014Cited by 500
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA groupD. Timmerman, L. Valentin, D. Fischerová et al.|BMJ|2010Cited by 473
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis groupD. Timmerman, L. Valentin, Ben Van Calster et al.|American Journal of Obstetrics and Gynecology|2016Cited by 329
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort studyWouter Froyman, D. Timmerman, C. Landolfo et al.|The Lancet Oncology|2019Cited by 188
Early-stage cervical cancer: Tumor delineation by magnetic resonance imaging and ultrasound — A European multicenter trialE. Epstein, D. Fischerová, A. C. Testa et al.|Gynecologic Oncology|2012Cited by 147